Skip to main
DLB

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories Inc. reported total revenues of $307.0 million, reflecting a year-over-year increase of approximately 1%, aligning closely with expectations. The company's full-year operating margins improved to 33.2%, up from 31.2% in the previous year, and overall revenue rose by 5.9% driven primarily by a 5.6% increase in licensing revenue and a robust 10% growth in product and services. Additionally, the increasing adoption of its technologies, particularly in emerging markets like China and India, along with continued growth potential in premium cinema technologies, contributes to a positive outlook for the company's financial trajectory.

Bears say

Dolby Laboratories Inc. is projecting a decline in revenue for fiscal 2026, expecting a high-single-digit decrease, which aligns with similar trends observed in fiscal 2025. The company's revised growth forecast for its Atmos/Vision/Patents business is now 15% to 20%, down from a previous estimate of 15% to 25%, indicating potential stagnation in a critical segment. Additionally, gross margins are decreasing, currently at 89.7% compared to 90.1% the previous year, suggesting pressure on profitability amidst challenges in device volumes and a challenging macro environment.

Dolby Laboratories (DLB) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 4 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Jan 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $92, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $92, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.